People living with someone who has COVID-19 appear to get powerful protection against infection when they are given Regeneron’s antibody cocktail, a new study shows. The findings suggest that beyond preventing the worst outcomes for coronavirus infection when given early enough, the cocktail could also prevent people from getting sick in the first place, the…  read on >  read on >

Once you’ve landed that coveted coronavirus vaccine appointment, you’ll likely have to fill out a form on your medical history and whether you’re allergic to any of the vaccine’s ingredients. But there could be another question waiting for you: Have you ever had dermal filler injections? That’s because — in rare cases — people who’ve…  read on >  read on >

People with cancers of the blood, bone marrow or lymph nodes are at an increased risk of not making protective coronavirus antibodies after COVID-19 vaccination, a new study warns. The risk is particularly high for those with chronic lymphocytic leukemia (CLL). The researchers urged these patients and those who interact with them to get vaccinated…  read on >  read on >

Older adults in long-term care develop detectible antibodies after COVID-19 vaccination, which may mean it’s safe to reopen these facilities, according to a new study. But because it’s unclear how long the antibodies last, researchers from University of Pittsburgh Medical Center (UPMC) say there’s still a need to monitor symptoms and controls on reopening. “COVID-19…  read on >  read on >

In a setback to a national vaccination campaign that was finally gaining ground, the federal government said Thursday that Johnson & Johnson will allocate 86 percent fewer doses of its coronavirus vaccine across the United States next week. The company delivered the first batch of its single-dose vaccine at the beginning of March, sending 2.8…  read on >  read on >